Brief: Tivic Health Systems Q2 Net Income USD -1.266 Million
14/08/2024 21:15
Aug 14 (Reuters) - Tivic Health Systems Q2 operating expenses USD 1.236 million. * Q2 basic EPS USD -0.32 * Q2 gross profit USD 30 thousand * Q2 operating income USD -1.206 million * Q2 revenue USD 140 thousand
Recent news on Valion Bio
See all newsBrief: Valion Bio Reports First Quarter 2026 Financial Results
Navigate FDA Submission
Brief: Tivic Health Systems Inc To Rebrand As Valion Bio, Ticker To Vbio Effective April 28, 2026
Brief: Tivic Health Systems Inc - Appoints Michael K. Handley As CEO And Board Member Effective March 3, 2026 - SEC Filing
Brief: Tivic Health Systems Enters Stock Purchase Agreement With Tumim Stone Capital